NIH OTT RSS Feed - Infectious Diseases - Therapeuticshttp://www.ott.nih.gov/rss/default.aspxOffice of Technology Transfer (OTT).Copyright 2009 NIH Office of Technology Transfer (OTT). All rights reserved.A Novel HIV-1 Entry Inhibitorhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25662013-05-22Novel Fusion Proteins for HIV Vaccinehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25672013-05-22New Molecules for HIV Therapeutics: Fab, scFv, and Related Binding Molecules Specific for HIV-1 Revhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=22422013-04-17HIV-Neutralizing Polypeptides: A Novel Use for Platelet Factor 4 or Its Derivativeshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25472013-04-04Human Antibodies and Fusion Proteins with Potent and Broad HIV-1 Neutralizing Activityhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=24822013-03-18Cross-Reactive Dengue Fully Human Monoclonal Antibodieshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25082013-03-18Novel Host Target for Treatment of Hepatitis C Virus Infectionhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25392013-03-18Small, Stable, Functional, Soluble, Monomeric IgG1 Fc Molecules Engineered Therapieshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25122013-02-19Murine Monoclonal Antibodies Effective To Treat Respiratory Syncytial Virushttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=3522013-02-14Enzymatically-Active RNA-Dependent RNA Polymerase From a Human Norovirus (Calicivirus)http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=9082013-02-14Construction of an Infectious Full-Length cDNA Clone of the Porcine Enteric Calicivirus RNA Genomehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=9092013-02-14Construction of Recombinant Baculoviruses Carrying the Gene Encoding the Major Capsid Protein, VP1, From Calicivirus Strains (Including Norovirus Strains Toronto, Hawaii, Desert Shield, Snow Mountain, and MD145-12)http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=9102013-02-14HIV Therapeutics Utilizing Peptide Secreting Commensal Bacteriahttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=10002013-02-13Human Cells and Nanoparticles to Enhance Immunotherapyhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23012013-02-13Therapeutic Hepatitis C Virus Antibodieshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25242013-02-05Transmission-Blocking Malaria Vaccinehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=25062013-01-11Exposing T cells to Fas Ligand (FasL)-Fas Receptor (FasR) Antagonists Withholds Differentiation and Increases Expansion Making T cells More Suitable for Use in Cancer Immunotherapyhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=24562012-12-04Topical Antibiotic with Immune Stimulating Oligodeoxynucleotide Molecules to Speed Wound Healinghttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=24872012-11-19Selective Treatment of Cancer, HIV, Other RNA Viruses and Genetically Related Diseases Using Therapeutic RNA Switcheshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=24952012-11-19Activation of Therapeutic Functionalities with Chimeric RNA/DNA Nanoparticles for Treatment of Cancer, Viruses and Other Diseaseshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=24962012-11-19Treatment of Tuberculosis ? Adjuvant Therapies to Increase the Efficiency of Antibiotic Treatmentshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23372012-11-16Cross-Reactive Neutralizing Human Domain Antibody Against HIV-1http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=18092012-09-28Method of Making a Vaccinehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=18992012-09-28Generation of Wild-Type Dengue Viruses for Use in Rhesus Monkey Infection Studieshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=17362012-09-12Methods of Treating Giardiasis Using FDA-Approved Compoundshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23072012-08-17Salen-Manganese Compounds for Therapy of Viral Infectionshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=24642012-07-20Linked Purine Pterin HPPK Inhibitors Useful as Antibacterial Agentshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=21692012-07-10New Ammunition to Fight Cancer: The Rapid Isolation of Central Memory T Cells for Adoptive Immunotherapyhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=24542012-07-10Treatment of Viral Infection by Blocking Interleukin-21http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=24482012-06-06Novel Reduced Toxicity Tropolone Derivative Compounds That Have Anti-Viral Activity Through Inhibiting RNase H Activityhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=24292012-05-08Induced Internalization of Surface Receptors to Disrupt Cell Surface Signalinghttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=18432012-05-01A Broadly Neutralizing Human Anti-HIV Monoclonal Antibody (10E8) Capable of Neutralizing Most HIV-1 Strainshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=24282012-05-01Nonpathogenic Bacteria, Paenibacillus alvei, Useful as a Natural Biocontrol Agent for Elimination of Food-borne Pathogenic Bacteriahttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23962012-04-23Method of Treating Hepatitis C Virus Infection With a Small Molecule CHK2 Inhibitorhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23882012-03-23A Novel Treatment for Malarial Infectionshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=18272012-02-13Clones Encoding Mammalian ADP-Ribosylarginine Hydrolaseshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=3992012-01-11Gas Permeable Flasks to Grow Tumor Infiltrating Lymphocytes (TIL) for More Effective Anti-Cancer Immunotherapyhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23122011-10-28Protease Deficient Bacillus anthracis with Improved Recombinant Protein Yield Capabilitieshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23302011-10-21Humanized Monoclonal Antibodies Efficient for Neutralization of Tick-Borne Encephalitis Virus (TBEV)http://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23192011-09-29PSM Peptides as Vaccine Targets Against Methicillin-Resistant Staphylococcus aureushttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=17172011-09-01Monoclonal Antibodies Against Poliovirushttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=23062011-08-12Method to Create Vaccines for the Prevention of Flavivirus Infections by Targeting Micro-RNAhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=22202011-08-02A New Class of Antibiotics: Naturally-occurring Chrysophaetins and Their Analogueshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=21232011-03-29Anti-Plasmodium Compositions and Methods of Usehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=11812011-02-28Aspartic Protease Inhibitors, Compositions, and Associated Therapeutic Methodshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=12212011-02-28Monoclonal Antibodies Against Dengue and Other Viruses With Deletion in Fc Regionhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=16082011-02-28Monoclonal Antibodies That Bind or Neutralize Dengue Virushttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=16842011-02-28Method of Treating and Preventing Infections in Immunocompromised Subjects with Immunostimulatory CpG Oligonucleotideshttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=17522011-02-28Anti-Plasmodium Compositions and Methods of Usehttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=18632011-02-28Compounds That Treat Malaria and Prevent Malaria Transmissionhttp://www.ott.nih.gov/Technologies/abstractDetails.aspx?RefNo=22012011-02-28